(S. Typhi) caused an estimated 9.24 million cases (5.94 M, 14.1 M) of typhoid fever in 2019,
resulting in 110 000 deaths (52 800, 191 000)[1]. Over 4.8 million cases and 50 000 deaths …

The disease burden of typhoid fever remains high in endemic areas in Asia and Africa,
especially in children. Recent clinical trials conducted by the Typhoid Vaccine Acceleration …

Typhoid fever is a serious disease that disproportionately impacts children in low-resource
settings in sub-Saharan Africa, South and Southeast Asia, and the Western Pacific. The …

Typhoid fever continues to be a major public health concern, particularly in many low-and
middle-income countries. The current threats of increasing antimicrobial resistance …

The 21 February 2018 was a day in vaccine history as 4-year old Golden Kondowe became
the first child in Africa to be enrolled in an individually randomized vaccine efficacy trial of a …

The emergence and spread of extensively drug-resistant (XDR) typhoid in Karachi, Pakistan
led to an outbreak response in Lyari Town, Karachi utilizing a mass immunization campaign …

Typhoid fever, an infection with potentially life threatening complications, is responsible for
11 to 21 million illness episodes and 145,000 to 161,000 deaths each year globally. India is …

Rabab Batool and colleagues1 report the efficacy and safety of typhoid vaccines in
preventing cultureconfirmed SalmonellaTyphi infections using a systematic review and meta …

Background Salmonella Typhi is a major cause of fever in children in low-and middle-
income countries. The recently WHO prequalified typhoid conjugate vaccine (TCV) was …

Abstract With a newly World Health Organization (WHO)–prequalified typhoid conjugate
vaccine (TCV), Gavi funding for eligible countries, and a WHO policy recommendation for …